← Back to Search

Behavioral Intervention

Project Self Education & Screening Kit for Cervical Cancer Prevention in Hispanic and African American Women

N/A
Waitlist Available
Led By Surendranath S Shastri
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 month
Awards & highlights
No Placebo-Only Group

Summary

This trial tests if Project Self can reduce cervical cancer screening disparities in Hispanic & African American women by providing HPV self-collection kits, education, counseling, & navigation.

Who is the study for?
This trial is for Hispanic and African American women living in Houston, Texas who identify as such, have a valid home address in certain housing developments, a working phone number, and can speak and read English or Spanish. Women with household members already enrolled, those who've had a hysterectomy, have had cancer or are pregnant cannot participate.
What is being tested?
Project Self aims to boost cervical cancer screening rates among the target demographic by providing HPV self-collection kits along with educational materials, counseling services, and guidance through the process.
What are the potential side effects?
Since this intervention involves education and self-collection of samples rather than medication or invasive procedures, there are no direct medical side effects. However participants may experience discomfort or anxiety related to the testing process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Human papillomavirus (HPV) self-collection uptake rate
Secondary study objectives
Screening procedure

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Screening (questionnaire, health education, self-collection)Experimental Treatment3 Interventions
Participants complete questionnaires, take part in a health education session, and receive HPV self-collection kit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HPV Self-Collection
2022
N/A
~20

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,925 Previous Clinical Trials
41,017,961 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
3,066 Previous Clinical Trials
1,802,205 Total Patients Enrolled
Surendranath S ShastriPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Project Self (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04614155 — N/A
Healthy Subjects Research Study Groups: Screening (questionnaire, health education, self-collection)
Healthy Subjects Clinical Trial 2023: Project Self Highlights & Side Effects. Trial Name: NCT04614155 — N/A
Project Self (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04614155 — N/A
~7 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top